bioRxiv · 10.1101/286955
How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion
Abstract
Dengue virus (DV) is a compact, icoshedrally symmetric, enveloped particle, covered by 90 dimers of envelope protein (E), which mediates viral attachment and membrane fusion. Fusion requires a dimer-to-trimer transition and membrane engagement of hydrophobic \"fusion loops\". We previously characterized the steps in membrane fusion for the related West Nile virus (WNV), using recombinant, WNV virus-like particles (VLPs) for single-particle experiments. Trimerization and membrane engagement are rate-limiting; fusion requires at least two adjacent trimers; availability of competent monomers within the contact zone between virus and target membrane creates a trimerization bottleneck. We have extended that work to dengue VLPs, from all four DV serotypes, finding an essentially similar mechanism. Small-molecule inhibitors of DV infection that target E block its fusion-inducing conformation change. We show that [~]15 bound molecules per particle ([~]8.5 % occupancy) completely prevent fusion, in accord with the proposed mechanism and the likely inhibitor binding site on E.\n\nImpact statementSingle-particle studies of dengue-virus membrane fusion and the effect of small-molecule inhibitors of infection clarify the viral fusion mechanism.
Source connections
Explore related subjects
Keep this discovery
Chao, L. H., Jang, J., Johnson, A., Nguyen, A., Gray, N. S., Yang, P. L., Harrison, S. C.. 2018-03-22. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion. https://doi.org/10.1101/286955
Cite the original work for its findings. Save a collection to share your selection of sources.